secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001737287-23-000023
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Allogene Therapeutics has no cash deposits or securities at Silicon Valley Bank
-------------------------------------------------------------------------------

- Company confirms zero exposure to SVB amid its closure and industry uncertainty.
- No cash or securities held at SVB; no financial impact from the bank's collapse.
- Disclosure aims to address investor concerns about counterparty risk.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000173728723000023/0001737287-23-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000173728723000023/allo-20230310.htm
  HTML page:      https://secwatch.observer/filing/0001737287-23-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer